Catalyst Biosciences vs VarmX

Catalyst Biosciences logo

Catalyst Biosciences

12 employees · est. 1997 · South San Francisco, United...

VS
VarmX logo

VarmX

VarmX is a young biotech company focusing on the development of therapies in the field of hemostasis and thrombosis

36 employees · est. 2016 · Leiden, The Netherlands

Catalyst Biosciences is the older company (1997 vs 2016).

Side-by-Side Comparison

Catalyst Biosciences VarmX
Founded
1997 older 2016
Headquarters
South San Francisco, United States Leiden, The Netherlands
Employees
12 36
Industry
Biopharma, Biotechnology, Life Sciences Biotechnology, Health and Wellness, Manufacturing
Funding Stage
Post-IPO Equity Acquired
Total Funding
$301.31M $205.30M
Funding Rounds
14 10
Services
Not tracked yet Development of universal bypassing agents, Restoration of blood coagulation, Clinical studies and publications
Target Customers
Not tracked yet Patients on Factor Xa Direct Oral Anticoagulants, Healthcare professionals, Medical institutions
Taxonomy
BiopharmaceuticalRare DisordersComplement SystemCoagulation SystemProtease EngineeringClinical Development +7 BiotechHemostasisThrombosisTherapeutic ProteinsCoagulation Factor XFactor Xa Inhibitors +9
Website
catalystbiosciences.com varmx.com
Catalyst Biosciences logo

About Catalyst Biosciences

Catalyst Biosciences is an innovative biopharmaceutical company founded in 1997, focused on rare disorders of the complement and coagulation systems within the Health Care industry. Their protease engineering platform has yielded significant results, leading to the development of several promising p...

VarmX logo

About VarmX

VarmX is a promising biotech company from The Netherlands, established in 2016. Focusing on the critical sectors of hemostasis and thrombosis, the company has its roots as a spin-off from the Leiden University Medical Center (LUMC). Its mission to develop therapeutic proteins aims to address bleedin...

Also comparing in this category

Comparing more than these two?

Get Catalyst Biosciences, VarmX and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Catalyst Biosciences compare?

A PDF of Catalyst Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

Catalyst Biosciences was founded in 1997, based in South San Francisco, United States, with 12 employees. Catalyst Biosciences is an innovative biopharmaceutical company founded in 1997, focused on rare disorders of the complement and coagulation systems within the Health Care industry. Their protease eng. VarmX was founded in 2016, based in Leiden, The Netherlands, with 36 employees. VarmX is a promising biotech company from The Netherlands, established in 2016. Focusing on the critical sectors of hemostasis and thrombosis, the company has its roots as a spin-off from the Leiden U.
Catalyst Biosciences has raised $301.31M and VarmX $205.30M. Latest stage: Catalyst Biosciences Post-IPO Equity, VarmX Acquired.
Both work in Biotechnology and Pharmaceutical.

Compare Catalyst Biosciences with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Catalyst Biosciences on 12 Sep 2024, and VarmX on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes